GenesisCare is the largest provider of cancer care services in Australia, with an expansive network of treatment centers across Australia, the United States, the United Kingdom, and Spain. Founded in 2005 by Dan Collins in Brisbane, the company specializes in radiation therapy, medical oncology, hematology, urology, surgery, and integrated cancer treatments. GenesisCare was treating more than 2,500 patients daily across more than 150 locations by 2016, demonstrating significant scale in delivering community-based cancer care.
The company's approach centers on providing personalized, multidisciplinary cancer treatment based on individual patient needs. GenesisCare combines expert clinical teams with innovative technologies and proven treatments to achieve optimal life outcomes. In a major corporate development, China Resources Group and Macquarie Capital acquired a 56% stake in the company for A$1.7 billion in 2016, enabling continued expansion. The US operations, specifically GenesisCare USA of Florida, were acquired by OneOncology in 2023 and have been rebranded as SunState Medical Specialists, while the broader GenesisCare organization continues operations in other markets.
